All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
CAT | Product Name | Target Species | Antibody Clone | Antibody Host | Receptor Construction | Vector Type | Targeting Cell Type | CAR Vector Type | Inquiry & Datasheet |
CAR-CQ2273 | Anti-SETDB2 (CBXS-3606) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | CBXS-3606 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-CQ2274 | Anti-SETDB2 (CBXS-0289) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | CBXS-0289 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-CQ2275 | Anti-SETDB2 (CBXS-2760) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | CBXS-2760 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-CQ2276 | Anti-SETDB2 (CBXS-2811) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | CBXS-2811 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-CQ2277 | Anti-SETDB2 (CBXS-2833) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | CBXS-2833 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-CQ5697 | Anti-SETDB2 (CBXS-3606) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | CBXS-3606 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-CQ5698 | Anti-SETDB2 (CBXS-0289) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | CBXS-0289 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-CQ5699 | Anti-SETDB2 (CBXS-2760) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | CBXS-2760 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-CQ5700 | Anti-SETDB2 (CBXS-2811) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | CBXS-2811 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-CQ5701 | Anti-SETDB2 (CBXS-2833) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | CBXS-2833 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell |
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTERCellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTIONSilence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGYCanine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION